Clinical trial opportunity for individuals with moderate-to-severe COPD symptoms

COPD, short for chronic obstructive pulmonary disease, includes chronic bronchitis and emphysema. It’s a long-term lung disease that makes it hard to breathe. Participating in clinical trials is one way to support the entire COPD population and help researchers develop treatment options at the same time. A new clinical trial is investigating the safety and efficacy of a drug with the aim of potentially reducing moderate-to-severe symptom flare-ups for some people living with COPD, and volunteers are needed.

Check eligibility

Study details

Eligibility requirements

Participants must:

  • be between 40-85 years old
  • have a diagnosis of COPD by a medical professional
  • be a current smoker or past smoker
  • have experienced 3 or more moderate to severe exacerbations

Participants must not:

  • have asthma (with the exception of childhood diagnosed asthma)
  • have active liver disease (Hep B or C)
  • have tuberculosis
  • have cirrhosis

If you would like to speak to someone regarding this trial, first check to see if you may be eligible above. If it seems that you may be eligible to take part, you will be contacted by phone so we can ask you additional eligibility questions, and you will be able to ask any additional questions you may have about this clinical trial.